Next Article in Journal
Primary Care Continuity and Wait Times to Receiving Breast Cancer Chemotherapy: A Population-Based Retrospective Cohort Study Using CanIMPACT Data
Previous Article in Journal
Oncology Care Provision: Planning for Today, Tomorrow, and Years to Come
Previous Article in Special Issue
Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience
Article

Impact of COVID-19 on Radiation Oncology, an Austrian Experience

1
Department of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria
2
Department of Neuroradiology, Medical University of Innsbruck, 6020 Innsbruck, Austria
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2021, 28(6), 4776-4785; https://doi.org/10.3390/curroncol28060404
Received: 6 October 2021 / Revised: 29 October 2021 / Accepted: 11 November 2021 / Published: 17 November 2021
(This article belongs to the Special Issue Cancer Care during COVID-19 Pandemic)
The COVID-19 pandemic has an unprecedented impact on cancer treatment worldwide. We aimed to evaluate the effects of the pandemic on the radiation treatment of patients in order to provide data for future management of such crises. We compared the number of performed radiotherapy sessions of the pandemic period from February 2020 until May 2021 with those of 2018 and 2019 for reference. At our department, no referred patients had to be rejected or postponed, nor any significant changes in fractionation schedules implemented. Nevertheless, there was a substantial drop in overall radiotherapy sessions in 2020 following the first incidence wave of up to −25% (in June) in comparison to previous years. For breast cancer, a maximum decline of sessions of −45% (July) was recorded. Only a short drop of prostate cancer sessions (max −35%, May) followed by a rebound (+42%, July) was observed. Over the investigated period, a loss of 4.4% of expected patients never recovered. The severe impact of COVID-19 on cancer treatment, likely caused by retarded diagnosis and delayed interdisciplinary co-treatment, is reflected in a lower count of radiotherapy sessions. Radiation oncology is a crucial cornerstone in upholding both curative treatment options and treatment capacity during a pandemic. View Full-Text
Keywords: COVID-19; SARS-CoV-2; cancer; radiotherapy COVID-19; SARS-CoV-2; cancer; radiotherapy
Show Figures

Figure 1

MDPI and ACS Style

Mangesius, J.; Arnold, C.R.; Seppi, T.; Mangesius, S.; Brüggl, M.; Eichberger, P.; Ganswindt, U. Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Curr. Oncol. 2021, 28, 4776-4785. https://doi.org/10.3390/curroncol28060404

AMA Style

Mangesius J, Arnold CR, Seppi T, Mangesius S, Brüggl M, Eichberger P, Ganswindt U. Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Current Oncology. 2021; 28(6):4776-4785. https://doi.org/10.3390/curroncol28060404

Chicago/Turabian Style

Mangesius, Julian, Christoph R. Arnold, Thomas Seppi, Stephanie Mangesius, Mario Brüggl, Paul Eichberger, and Ute Ganswindt. 2021. "Impact of COVID-19 on Radiation Oncology, an Austrian Experience" Current Oncology 28, no. 6: 4776-4785. https://doi.org/10.3390/curroncol28060404

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop